1 Poliomyelitis Vaccines Market Overview 1.1 Poliomyelitis Vaccines Product Scope 1.2 Poliomyelitis Vaccines Segment by Type 1.2.1 Global Poliomyelitis Vaccines Sales by Type (2016 & 2021 & 2027) 1.2.2 IPV 1.2.3 OPV 1.3 Poliomyelitis Vaccines Segment by Application 1.3.1 Global Poliomyelitis Vaccines Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Research & Academic Laboratories 1.3.3 Pharmaceutical & Biotechnology Companies 1.3.4 Others 1.4 Poliomyelitis Vaccines Market Estimates and Forecasts (2016-2027) 1.4.1 Global Poliomyelitis Vaccines Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Poliomyelitis Vaccines Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Poliomyelitis Vaccines Price Trends (2016-2027) 2 Poliomyelitis Vaccines Estimates and Forecasts by Region 2.1 Global Poliomyelitis Vaccines Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Poliomyelitis Vaccines Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Poliomyelitis Vaccines Sales Market Share by Region (2016-2021) 2.2.2 Global Poliomyelitis Vaccines Revenue Market Share by Region (2016-2021) 2.3 Global Poliomyelitis Vaccines Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Poliomyelitis Vaccines Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Poliomyelitis Vaccines Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Poliomyelitis Vaccines Estimates and Projections (2016-2027) 2.4.2 Europe Poliomyelitis Vaccines Estimates and Projections (2016-2027) 2.4.3 China Poliomyelitis Vaccines Estimates and Projections (2016-2027) 2.4.4 Japan Poliomyelitis Vaccines Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Poliomyelitis Vaccines Estimates and Projections (2016-2027) 2.4.6 India Poliomyelitis Vaccines Estimates and Projections (2016-2027) 3 Global Poliomyelitis Vaccines Competition Landscape by Players 3.1 Global Top Poliomyelitis Vaccines Players by Sales (2016-2021) 3.2 Global Top Poliomyelitis Vaccines Players by Revenue (2016-2021) 3.3 Global Poliomyelitis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poliomyelitis Vaccines as of 2020) 3.4 Global Poliomyelitis Vaccines Average Price by Company (2016-2021) 3.5 Manufacturers Poliomyelitis Vaccines Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Poliomyelitis Vaccines Market Size by Type 4.1 Global Poliomyelitis Vaccines Historic Market Review by Type (2016-2021) 4.1.1 Global Poliomyelitis Vaccines Sales Market Share by Type (2016-2021) 4.1.2 Global Poliomyelitis Vaccines Revenue Market Share by Type (2016-2021) 4.1.3 Global Poliomyelitis Vaccines Price by Type (2016-2021) 4.2 Global Poliomyelitis Vaccines Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Poliomyelitis Vaccines Sales Forecast by Type (2022-2027) 4.2.2 Global Poliomyelitis Vaccines Revenue Forecast by Type (2022-2027) 4.2.3 Global Poliomyelitis Vaccines Price Forecast by Type (2022-2027) 5 Global Poliomyelitis Vaccines Market Size by Application 5.1 Global Poliomyelitis Vaccines Historic Market Review by Application (2016-2021) 5.1.1 Global Poliomyelitis Vaccines Sales Market Share by Application (2016-2021) 5.1.2 Global Poliomyelitis Vaccines Revenue Market Share by Application (2016-2021) 5.1.3 Global Poliomyelitis Vaccines Price by Application (2016-2021) 5.2 Global Poliomyelitis Vaccines Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Poliomyelitis Vaccines Sales Forecast by Application (2022-2027) 5.2.2 Global Poliomyelitis Vaccines Revenue Forecast by Application (2022-2027) 5.2.3 Global Poliomyelitis Vaccines Price Forecast by Application (2022-2027) 6 North America Poliomyelitis Vaccines Market Facts & Figures 6.1 North America Poliomyelitis Vaccines Sales by Company 6.1.1 North America Poliomyelitis Vaccines Sales by Company (2016-2021) 6.1.2 North America Poliomyelitis Vaccines Revenue by Company (2016-2021) 6.2 North America Poliomyelitis Vaccines Sales Breakdown by Type 6.2.1 North America Poliomyelitis Vaccines Sales Breakdown by Type (2016-2021) 6.2.2 North America Poliomyelitis Vaccines Sales Breakdown by Type (2022-2027) 6.3 North America Poliomyelitis Vaccines Sales Breakdown by Application 6.3.1 North America Poliomyelitis Vaccines Sales Breakdown by Application (2016-2021) 6.3.2 North America Poliomyelitis Vaccines Sales Breakdown by Application (2022-2027) 7 Europe Poliomyelitis Vaccines Market Facts & Figures 7.1 Europe Poliomyelitis Vaccines Sales by Company 7.1.1 Europe Poliomyelitis Vaccines Sales by Company (2016-2021) 7.1.2 Europe Poliomyelitis Vaccines Revenue by Company (2016-2021) 7.2 Europe Poliomyelitis Vaccines Sales Breakdown by Type 7.2.1 Europe Poliomyelitis Vaccines Sales Breakdown by Type (2016-2021) 7.2.2 Europe Poliomyelitis Vaccines Sales Breakdown by Type (2022-2027) 7.3 Europe Poliomyelitis Vaccines Sales Breakdown by Application 7.3.1 Europe 123 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 123 Sales Breakdown by Application (2022-2027) 8 China Poliomyelitis Vaccines Market Facts & Figures 8.1 China Poliomyelitis Vaccines Sales by Company 8.1.1 China Poliomyelitis Vaccines Sales by Company (2016-2021) 8.1.2 China Poliomyelitis Vaccines Revenue by Company (2016-2021) 8.2 China Poliomyelitis Vaccines Sales Breakdown by Type 8.2.1 China Poliomyelitis Vaccines Sales Breakdown by Type (2016-2021) 8.2.2 China Poliomyelitis Vaccines Sales Breakdown by Type (2022-2027) 8.3 China Poliomyelitis Vaccines Sales Breakdown by Application 8.3.1 China 144 Sales Breakdown by Application (2016-2021) 8.3.2 China 144 Sales Breakdown by Application (2022-2027) 9 Japan Poliomyelitis Vaccines Market Facts & Figures 9.1 Japan Poliomyelitis Vaccines Sales by Company 9.1.1 Japan Poliomyelitis Vaccines Sales by Company (2016-2021) 9.1.2 Japan Poliomyelitis Vaccines Revenue by Company (2016-2021) 9.2 Japan Poliomyelitis Vaccines Sales Breakdown by Type 9.2.1 Japan Poliomyelitis Vaccines Sales Breakdown by Type (2016-2021) 9.2.2 Japan Poliomyelitis Vaccines Sales Breakdown by Type (2022-2027) 9.3 Japan Poliomyelitis Vaccines Sales Breakdown by Application 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Poliomyelitis Vaccines Market Facts & Figures 10.1 Southeast Asia Poliomyelitis Vaccines Sales by Company 10.1.1 Southeast Asia Poliomyelitis Vaccines Sales by Company (2016-2021) 10.1.2 Southeast Asia Poliomyelitis Vaccines Revenue by Company (2016-2021) 10.2 Southeast Asia Poliomyelitis Vaccines Sales Breakdown by Type 10.2.1 Southeast Asia Poliomyelitis Vaccines Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Poliomyelitis Vaccines Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Poliomyelitis Vaccines Sales Breakdown by Application 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Poliomyelitis Vaccines Market Facts & Figures 11.1 India Poliomyelitis Vaccines Sales by Company 11.1.1 India Poliomyelitis Vaccines Sales by Company (2016-2021) 11.1.2 India Poliomyelitis Vaccines Revenue by Company (2016-2021) 11.2 India Poliomyelitis Vaccines Sales Breakdown by Type 11.2.1 India Poliomyelitis Vaccines Sales Breakdown by Type (2016-2021) 11.2.2 India Poliomyelitis Vaccines Sales Breakdown by Type (2022-2027) 11.3 India Poliomyelitis Vaccines Sales Breakdown by Application 11.3.1 India Poliomyelitis Vaccines Sales Breakdown by Application (2016-2021) 11.3.2 India Poliomyelitis Vaccines Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Poliomyelitis Vaccines Business 12.1 Sanofi 12.1.1 Sanofi Corporation Information 12.1.2 Sanofi Business Overview 12.1.3 Sanofi Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Sanofi Poliomyelitis Vaccines Products Offered 12.1.5 Sanofi Recent Development 12.2 GSK 12.2.1 GSK Corporation Information 12.2.2 GSK Business Overview 12.2.3 GSK Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.2.4 GSK Poliomyelitis Vaccines Products Offered 12.2.5 GSK Recent Development 12.3 Bibcol 12.3.1 Bibcol Corporation Information 12.3.2 Bibcol Business Overview 12.3.3 Bibcol Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Bibcol Poliomyelitis Vaccines Products Offered 12.3.5 Bibcol Recent Development 12.4 Serum Institute 12.4.1 Serum Institute Corporation Information 12.4.2 Serum Institute Business Overview 12.4.3 Serum Institute Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Serum Institute Poliomyelitis Vaccines Products Offered 12.4.5 Serum Institute Recent Development 12.5 Tiantan Biological 12.5.1 Tiantan Biological Corporation Information 12.5.2 Tiantan Biological Business Overview 12.5.3 Tiantan Biological Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Tiantan Biological Poliomyelitis Vaccines Products Offered 12.5.5 Tiantan Biological Recent Development 12.6 IMBCA 12.6.1 IMBCA Corporation Information 12.6.2 IMBCA Business Overview 12.6.3 IMBCA Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.6.4 IMBCA Poliomyelitis Vaccines Products Offered 12.6.5 IMBCA Recent Development 12.7 Panacea Biotec Ltd 12.7.1 Panacea Biotec Ltd Corporation Information 12.7.2 Panacea Biotec Ltd Business Overview 12.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Panacea Biotec Ltd Poliomyelitis Vaccines Products Offered 12.7.5 Panacea Biotec Ltd Recent Development 12.8 Bio-Med 12.8.1 Bio-Med Corporation Information 12.8.2 Bio-Med Business Overview 12.8.3 Bio-Med Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Bio-Med Poliomyelitis Vaccines Products Offered 12.8.5 Bio-Med Recent Development 12.9 Halfkin Bio-Pharmaceuticals 12.9.1 Halfkin Bio-Pharmaceuticals Corporation Information 12.9.2 Halfkin Bio-Pharmaceuticals Business Overview 12.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Products Offered 12.9.5 Halfkin Bio-Pharmaceuticals Recent Development 13 Poliomyelitis Vaccines Manufacturing Cost Analysis 13.1 Poliomyelitis Vaccines Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Poliomyelitis Vaccines 13.4 Poliomyelitis Vaccines Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Poliomyelitis Vaccines Distributors List 14.3 Poliomyelitis Vaccines Customers 15 Market Dynamics 15.1 Poliomyelitis Vaccines Market Trends 15.2 Poliomyelitis Vaccines Drivers 15.3 Poliomyelitis Vaccines Market Challenges 15.4 Poliomyelitis Vaccines Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Poliomyelitis Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Poliomyelitis Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Poliomyelitis Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Poliomyelitis Vaccines Sales (K Units) by Region (2016-2021) Table 5. Global Poliomyelitis Vaccines Sales Market Share by Region (2016-2021) Table 6. Global Poliomyelitis Vaccines Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Poliomyelitis Vaccines Revenue Share by Region (2016-2021) Table 8. Global Poliomyelitis Vaccines Sales (K Units) Forecast by Region (2022-2027) Table 9. Global Poliomyelitis Vaccines Sales Market Share Forecast by Region (2022-2027) Table 10. Global Poliomyelitis Vaccines Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Poliomyelitis Vaccines Revenue Share Forecast by Region (2022-2027) Table 12. Global Poliomyelitis Vaccines Sales (K Units) of Key Companies (2016-2021) Table 13. Global Poliomyelitis Vaccines Sales Share by Company (2016-2021) Table 14. Global Poliomyelitis Vaccines Revenue (US$ Million) by Company (2016-2021) Table 15. Global Poliomyelitis Vaccines Revenue Share by Company (2016-2021) Table 16. Global Poliomyelitis Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Poliomyelitis Vaccines as of 2020) Table 17. Global Poliomyelitis Vaccines Average Price (USD/Unit) of Key Company (2016-2021) Table 18. Manufacturers Poliomyelitis Vaccines Manufacturing Sites and Area Served Table 19. Manufacturers Poliomyelitis Vaccines Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Poliomyelitis Vaccines Sales (K Units) by Type (2016-2021) Table 22. Global Poliomyelitis Vaccines Sales Share by Type (2016-2021) Table 23. Global Poliomyelitis Vaccines Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Poliomyelitis Vaccines Price (USD/Unit) by Type (2016-2021) Table 25. Global Poliomyelitis Vaccines Sales Share by Type (2022-2027) Table 26. Global Poliomyelitis Vaccines Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Poliomyelitis Vaccines Revenue Share by Type (2022-2027) Table 28. Global Poliomyelitis Vaccines Price (USD/Unit) by Type (2022-2027) Table 29. Global Poliomyelitis Vaccines Sales (K Units) by Application (2016-2021) Table 30. Global Poliomyelitis Vaccines Sales Share by Application (2016-2021) Table 31. Global Poliomyelitis Vaccines Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Poliomyelitis Vaccines Price (USD/Unit) by Application (2016-2021) Table 33. Global Poliomyelitis Vaccines Sales (K Units) by Application (2022-2027) Table 34. Global Poliomyelitis Vaccines Sales Share by Application (2022-2027) Table 35. Global Poliomyelitis Vaccines Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Poliomyelitis Vaccines Revenue Share by Application (2022-2027) Table 37. Global Poliomyelitis Vaccines Price (USD/Unit) by Application (2022-2027) Table 38. North America Poliomyelitis Vaccines Sales (K Units) by Company (2016-2021) Table 39. North America Poliomyelitis Vaccines Sales Market Share by Company (2016-2021) Table 40. North America Poliomyelitis Vaccines Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Poliomyelitis Vaccines Revenue Market Share by Company (2016-2021) Table 42. North America Poliomyelitis Vaccines Sales by Type (2016-2021) & (K Units) Table 43. North America Poliomyelitis Vaccines Sales Market Share by Type (2016-2021) Table 44. North America Poliomyelitis Vaccines Sales by Type (2022-2027) & (K Units) Table 45. North America Poliomyelitis Vaccines Sales Market Share by Type (2022-2027) Table 46. North America Poliomyelitis Vaccines Sales by Application (2016-2021) & (K Units) Table 47. North America Poliomyelitis Vaccines Sales Market Share by Application (2016-2021) Table 48. North America Poliomyelitis Vaccines Sales by Application (2022-2027) & (K Units) Table 49. North America Poliomyelitis Vaccines Sales Market Share by Application (2022-2027) Table 50. Europe Poliomyelitis Vaccines Sales (K Units) by Company (2016-2021) Table 51. Europe Poliomyelitis Vaccines Sales Market Share by Company (2016-2021) Table 52. Europe Poliomyelitis Vaccines Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Poliomyelitis Vaccines Revenue Market Share by Company (2016-2021) Table 54. Europe Poliomyelitis Vaccines Sales by Type (2016-2021) & (K Units) Table 55. Europe Poliomyelitis Vaccines Sales Market Share by Type (2016-2021) Table 56. Europe Poliomyelitis Vaccines Sales by Type (2022-2027) & (K Units) Table 57. Europe Poliomyelitis Vaccines Sales Market Share by Type (2022-2027) Table 58. Europe Poliomyelitis Vaccines Sales by Application (2016-2021) & (K Units) Table 59. Europe Poliomyelitis Vaccines Sales Market Share by Application (2016-2021) Table 60. Europe Poliomyelitis Vaccines Sales by Application (2022-2027) & (K Units) Table 61. Europe Poliomyelitis Vaccines Sales Market Share by Application (2022-2027) Table 62. China Poliomyelitis Vaccines Sales (K Units) by Company (2016-2021) Table 63. China Poliomyelitis Vaccines Sales Market Share by Company (2016-2021) Table 64. China Poliomyelitis Vaccines Revenue by Company (2016-2021) & (US$ Million) Table 65. China Poliomyelitis Vaccines Revenue Market Share by Company (2016-2021) Table 66. China Poliomyelitis Vaccines Sales by Type (2016-2021) & (K Units) Table 67. China Poliomyelitis Vaccines Sales Market Share by Type (2016-2021) Table 68. China Poliomyelitis Vaccines Sales by Type (2022-2027) & (K Units) Table 69. China Poliomyelitis Vaccines Sales Market Share by Type (2022-2027) Table 70. China Poliomyelitis Vaccines Sales by Application (2016-2021) & (K Units) Table 71. China Poliomyelitis Vaccines Sales Market Share by Application (2016-2021) Table 72. China Poliomyelitis Vaccines Sales by Application (2022-2027) & (K Units) Table 73. China Poliomyelitis Vaccines Sales Market Share by Application (2022-2027) Table 74. Japan Poliomyelitis Vaccines Sales (K Units) by Company (2016-2021) Table 75. Japan Poliomyelitis Vaccines Sales Market Share by Company (2016-2021) Table 76. Japan Poliomyelitis Vaccines Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Poliomyelitis Vaccines Revenue Market Share by Company (2016-2021) Table 78. Japan Poliomyelitis Vaccines Sales by Type (2016-2021) & (K Units) Table 79. Japan Poliomyelitis Vaccines Sales Market Share by Type (2016-2021) Table 80. Japan Poliomyelitis Vaccines Sales by Type (2022-2027) & (K Units) Table 81. Japan Poliomyelitis Vaccines Sales Market Share by Type (2022-2027) Table 82. Japan Poliomyelitis Vaccines Sales by Application (2016-2021) & (K Units) Table 83. Japan Poliomyelitis Vaccines Sales Market Share by Application (2016-2021) Table 84. Japan Poliomyelitis Vaccines Sales by Application (2022-2027) & (K Units) Table 85. Japan Poliomyelitis Vaccines Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Poliomyelitis Vaccines Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia Poliomyelitis Vaccines Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Poliomyelitis Vaccines Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Poliomyelitis Vaccines Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Poliomyelitis Vaccines Sales by Type (2016-2021) & (K Units) Table 91. Southeast Asia Poliomyelitis Vaccines Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Poliomyelitis Vaccines Sales by Type (2022-2027) & (K Units) Table 93. Southeast Asia Poliomyelitis Vaccines Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Poliomyelitis Vaccines Sales by Application (2016-2021) & (K Units) Table 95. Southeast Asia Poliomyelitis Vaccines Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Poliomyelitis Vaccines Sales by Application (2022-2027) & (K Units) Table 97. Southeast Asia Poliomyelitis Vaccines Sales Market Share by Application (2022-2027) Table 98. India Poliomyelitis Vaccines Sales (K Units) by Company (2016-2021) Table 99. India Poliomyelitis Vaccines Sales Market Share by Company (2016-2021) Table 100. India Poliomyelitis Vaccines Revenue by Company (2016-2021) & (US$ Million) Table 101. India Poliomyelitis Vaccines Revenue Market Share by Company (2016-2021) Table 102. India Poliomyelitis Vaccines Sales by Type (2016-2021) & (K Units) Table 103. India Poliomyelitis Vaccines Sales Market Share by Type (2016-2021) Table 104. India Poliomyelitis Vaccines Sales by Type (2022-2027) & (K Units) Table 105. India Poliomyelitis Vaccines Sales Market Share by Type (2022-2027) Table 106. India Poliomyelitis Vaccines Sales by Application (2016-2021) & (K Units) Table 107. India Poliomyelitis Vaccines Sales Market Share by Application (2016-2021) Table 108. India Poliomyelitis Vaccines Sales by Application (2022-2027) & (K Units) Table 109. India Poliomyelitis Vaccines Sales Market Share by Application (2022-2027) Table 110. Sanofi Corporation Information Table 111. Sanofi Description and Business Overview Table 112. Sanofi Poliomyelitis Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 113. Sanofi Poliomyelitis Vaccines Product Table 114. Sanofi Recent Development Table 115. GSK Corporation Information Table 116. GSK Description and Business Overview Table 117. GSK Poliomyelitis Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 118. GSK Poliomyelitis Vaccines Product Table 119. GSK Recent Development Table 120. Bibcol Corporation Information Table 121. Bibcol Description and Business Overview Table 122. Bibcol Poliomyelitis Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 123. Bibcol Poliomyelitis Vaccines Product Table 124. Bibcol Recent Development Table 125. Serum Institute Corporation Information Table 126. Serum Institute Description and Business Overview Table 127. Serum Institute Poliomyelitis Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 128. Serum Institute Poliomyelitis Vaccines Product Table 129. Serum Institute Recent Development Table 130. Tiantan Biological Corporation Information Table 131. Tiantan Biological Description and Business Overview Table 132. Tiantan Biological Poliomyelitis Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 133. Tiantan Biological Poliomyelitis Vaccines Product Table 134. Tiantan Biological Recent Development Table 135. IMBCA Corporation Information Table 136. IMBCA Description and Business Overview Table 137. IMBCA Poliomyelitis Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 138. IMBCA Poliomyelitis Vaccines Product Table 139. IMBCA Recent Development Table 140. Panacea Biotec Ltd Corporation Information Table 141. Panacea Biotec Ltd Description and Business Overview Table 142. Panacea Biotec Ltd Poliomyelitis Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 143. Panacea Biotec Ltd Poliomyelitis Vaccines Product Table 144. Panacea Biotec Ltd Recent Development Table 145. Bio-Med Corporation Information Table 146. Bio-Med Poliomyelitis Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 147. Bio-Med Description and Business Overview Table 148. Bio-Med Poliomyelitis Vaccines Product Table 149. Bio-Med Recent Development Table 150. Halfkin Bio-Pharmaceuticals Corporation Information Table 151. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 152. Halfkin Bio-Pharmaceuticals Description and Business Overview Table 153. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Table 154. Halfkin Bio-Pharmaceuticals Recent Development Table 155. Production Base and Market Concentration Rate of Raw Material Table 156. Key Suppliers of Raw Materials Table 157. Poliomyelitis Vaccines Distributors List Table 158. Poliomyelitis Vaccines Customers List Table 159. Poliomyelitis Vaccines Market Trends Table 160. Poliomyelitis Vaccines Market Drivers Table 161. Poliomyelitis Vaccines Market Challenges Table 162. Poliomyelitis Vaccines Market Restraints Table 163. Research Programs/Design for This Report Table 164. Key Data Information from Secondary Sources Table 165. Key Data Information from Primary Sources List of Figures Figure 1. Poliomyelitis Vaccines Product Picture Figure 2. Global Poliomyelitis Vaccines Sales Market Share by Type in 2021 & 2027 Figure 3. IPV Product Picture Figure 4. OPV Product Picture Figure 5. Global Poliomyelitis Vaccines Sales Market Share by Application in 2021 & 2027 Figure 6. Research & Academic Laboratories Examples Figure 7. Pharmaceutical & Biotechnology Companies Examples Figure 8. Others Examples Figure 9. Global Poliomyelitis Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Poliomyelitis Vaccines Sales Growth Rate (2016-2027) & (US$ Million) Figure 11. Global Poliomyelitis Vaccines Sales (K Units) Growth Rate (2016-2027) Figure 12. Global Poliomyelitis Vaccines Price Trends Growth Rate (2016-2027) (USD/Unit) Figure 13. Global Poliomyelitis Vaccines Revenue Market Share by Region: 2016 VS 2021 Figure 14. Global Poliomyelitis Vaccines Revenue Market Share by Region: 2021 VS 2027 Figure 15. North America Poliomyelitis Vaccines Revenue (Million USD) Growth Rate (2016-2027) Figure 16. North America Poliomyelitis Vaccines Sales (K Units) Growth Rate (2016-2027) Figure 17. Europe Poliomyelitis Vaccines Revenue (Million USD) Growth Rate (2016-2027) Figure 18. Europe Poliomyelitis Vaccines Sales (Million USD) Growth Rate (2016-2027) Figure 19. China Poliomyelitis Vaccines Revenue (Million USD) Growth Rate (2016-2027) Figure 20. China Poliomyelitis Vaccines Sales (Million USD) and Growth Rate (2016-2027) Figure 21. Japan Poliomyelitis Vaccines Revenue (Million USD) Growth Rate (2016-2027) Figure 22. Japan Poliomyelitis Vaccines Sales (Million USD) Growth Rate (2016-2027) Figure 23. Southeast Asia Poliomyelitis Vaccines Revenue (Million USD) Growth Rate (2016-2027) Figure 24. Southeast Asia Poliomyelitis Vaccines Sales (Million USD) Growth Rate (2016-2027) Figure 25. India Poliomyelitis Vaccines Revenue (Million USD) Growth Rate (2016-2027) Figure 26. India Poliomyelitis Vaccines Sales (Million USD) Growth Rate (2016-2027) Figure 27. Global 5 Largest Poliomyelitis Vaccines Players Market Share by Revenue in Poliomyelitis Vaccines: 2016 & 2020 Figure 28. Poliomyelitis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 29. Global Poliomyelitis Vaccines Revenue Share by Type (2016-2021) Figure 30. Global Poliomyelitis Vaccines Revenue Growth Rate by Type in 2016 & 2020 Figure 31. Global Poliomyelitis Vaccines Revenue Share by Application (2016-2021) Figure 32. Global Poliomyelitis Vaccines Revenue Growth Rate by Application in 2016 & 2020 Figure 33. North America Poliomyelitis Vaccines Sales Market Share by Type in 2020 Figure 34. North America Poliomyelitis Vaccines Sales Market Share by Application in 2020 Figure 35. Europe Poliomyelitis Vaccines Sales Market Share by Type in 2020 Figure 36. Europe Poliomyelitis Vaccines Sales Market Share by Application in 2020 Figure 37. China Poliomyelitis Vaccines Sales Market Share by Type in 2020 Figure 38. China Poliomyelitis Vaccines Sales Market Share by Application in 2020 Figure 39. Japan Poliomyelitis Vaccines Sales Market Share by Type in 2020 Figure 40. Japan Poliomyelitis Vaccines Sales Market Share by Application in 2020 Figure 41. Southeast Asia Poliomyelitis Vaccines Sales Market Share by Type in 2020 Figure 42. Southeast Asia Poliomyelitis Vaccines Sales Market Share by Application in 2020 Figure 43. India Poliomyelitis Vaccines Sales Market Share by Type in 2020 Figure 44. India Poliomyelitis Vaccines Sales Market Share by Application in 2020 Figure 45. Key Raw Materials Price Trend Figure 46. Manufacturing Cost Structure of Poliomyelitis Vaccines Figure 47. Manufacturing Process Analysis of Poliomyelitis Vaccines Figure 48. Poliomyelitis Vaccines Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Sanofi GSK Bibcol Serum Institute Tiantan Biological IMBCA Panacea Biotec Ltd Bio-Med Halfkin Bio-Pharmaceuticals